RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.72B
AUM Growth
-$153M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
30
New
Increased
Reduced
Closed

Top Buys

1
+$169M
2
+$76.2M
3
+$24.5M
4
MRNA icon
Moderna
MRNA
+$23.1M
5
ZGNX
Zogenix, Inc.
ZGNX
+$18.4M

Top Sells

1
+$110M
2
+$49.6M
3
+$19M
4
APLS icon
Apellis Pharmaceuticals
APLS
+$16M
5
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$15.8M

Sector Composition

1 Healthcare 95.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
– –
-900,000
27
– –
-2,535
28
– –
-350,933
29
– –
-3,030,303
30
– –
-6,196,143
1
2